Brief Summary
Type:
Multiple Sites (Solid Tumors)
Study Type:
Prevention
Phase:
II
ClinicalTrials.gov Identifier:
NCT02717507
Study #:
CMH - ALTE1621
Start Date:
Dec 31, 2017
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02717507
View Complete Trial Details & Eligibility at ClinicalTrials.gov
